AFST in Immunocompromised Patients
Immunocompromised patients—transplant recipients, cancer patients, HIV patients—are at high risk for fungal infections. Rapid, accurate testing is essential. This population drives demand in the AFST market. Within the Antifungal Susceptibility Testing Market, immunocompromised patients are a key segment. Testing guides critical treatment decisions. Geographically, demand is...
0 Comentários 0 Compartilhamentos 17 Visualizações 0 Anterior